These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20817366)

  • 1. Anaemia of prematurity: pathophysiology and treatment.
    Strauss RG
    Blood Rev; 2010 Nov; 24(6):221-5. PubMed ID: 20817366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of recombinant erythropoietin in treatment of the anemia of prematurity.
    Halpérin DS
    Am J Pediatr Hematol Oncol; 1991; 13(3):351-63. PubMed ID: 1793163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mathematical modeling approach to quantify the role of phlebotomy losses and need for transfusions in neonatal anemia.
    Rosebraugh MR; Widness JA; Nalbant D; Veng-Pedersen P
    Transfusion; 2013 Jun; 53(6):1353-60. PubMed ID: 23033916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal anemia: pathophysiology and treatment.
    Strauss RG
    Immunol Invest; 1995; 24(1-2):341-51. PubMed ID: 7713595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell transfusion practices in the neonate.
    Strauss RG
    Clin Perinatol; 1995 Sep; 22(3):641-55. PubMed ID: 8521686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal anemia.
    Aher S; Malwatkar K; Kadam S
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):239-47. PubMed ID: 18411074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2014 Apr; (4):CD004868. PubMed ID: 24760628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study.
    Shannon KM; Mentzer WC; Abels RI; Wertz M; Thayer-Moriyama J; Li WY; Thompson D; Decelle S; Phibbs RH
    J Pediatr; 1992 Apr; 120(4 Pt 1):586-92. PubMed ID: 1372652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential for treatment of anemia of prematurity with recombinant human erythropoietin.
    Phibbs RH
    Curr Opin Pediatr; 1995 Apr; 7(2):140-5. PubMed ID: 7787927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004868. PubMed ID: 22972077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trial-related blood sampling and red blood cell transfusions in preterm infants.
    Lewis AE; Kappel SS; Hussain S; Sangild PT; Zachariassen G; Aunsholt L
    Acta Paediatr; 2023 Dec; 112(12):2486-2492. PubMed ID: 37565393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of transfusion in anemia of very low birth weight infants.
    Jeon GW; Sin JB
    Yonsei Med J; 2013 Mar; 54(2):366-73. PubMed ID: 23364969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in red blood cell transfusions among preterm infants: results of a randomized trial with an in-line blood gas and chemistry monitor.
    Widness JA; Madan A; Grindeanu LA; Zimmerman MB; Wong DK; Stevenson DK
    Pediatrics; 2005 May; 115(5):1299-306. PubMed ID: 15867038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current controversies in the management of the anemia of prematurity.
    Bishara N; Ohls RK
    Semin Perinatol; 2009 Feb; 33(1):29-34. PubMed ID: 19167579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004863. PubMed ID: 22972076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with red blood cell transfusions in very-low-birth-weight preterm infants in Brazilian neonatal units.
    dos Santos AM; Guinsburg R; de Almeida MF; Procianoy RS; Marba ST; Ferri WA; Rugolo LM; Lopes JM; Moreira ME; Luz JH; González MR; Meneses Jdo A; da Silva RV; Abdallah VO; Duarte JL; Marques PF; Rego MA; Alves Filho N; Krebs VL;
    BMC Pediatr; 2015 Sep; 15():113. PubMed ID: 26341125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial.
    Ohls RK; Ehrenkranz RA; Wright LL; Lemons JA; Korones SB; Stoll BJ; Stark AR; Shankaran S; Donovan EF; Close NC; Das A
    Pediatrics; 2001 Oct; 108(4):934-42. PubMed ID: 11581447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing the anemia of prematurity: red blood cell transfusions versus recombinant erythropoietin.
    Strauss RG
    Transfus Med Rev; 2001 Jul; 15(3):213-23. PubMed ID: 11471123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of blood sampling stewardship and erythropoietin administration in extremely low birth weight infants-a quality improvement non-controlled before-and-after retrospective study.
    Balasubramanian H; Atyalgade M; Garg B; Srinivasan L; Kabra NS; Khapekar S
    Eur J Pediatr; 2021 May; 180(5):1617-1626. PubMed ID: 33464366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.